Dergiler / European Journal of Rheumatology / 2019 / Cilt: 6 - Sayı: 2

Serum hepcidin level and rheumatoid arthritis disease activity

Sayfa
76–80
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, it is not necessary tomeasure hepcidin to determine the RA activity.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The present study aimed to determine the relationship between the serum hepcidin leveland disease activity in patients with rheumatoid arthritis (RA).Methods: This study was conducted on 80 patients with RA (36 cases with anemia of chronic disease[ACD] and 44 patients without ACD).
📊
Temel Bulgular & Veri:Disease activity was measured by the 28-joint Disease ActivityScore based on the erythrocyte sedimentation rate (DAS28-ESR).
💡
Sonuç & Katkı:Therefore, it is not necessary tomeasure hepcidin to determine the RA activity.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: The present study aimed to determine the relationship between the serum hepcidin leveland disease activity in patients with rheumatoid arthritis (RA).Methods: This study was conducted on 80 patients with RA (36 cases with anemia of chronic disease[ACD] and 44 patients without ACD). Disease activity was measured by the 28-joint Disease ActivityScore based on the erythrocyte sedimentation rate (DAS28-ESR). According to the DAS28-ESR score,52 and 28 cases were categorized as inactive to moderately active RA (DAS28-ESR≤5.1) and highlyactive RA (DAS28-ESR>5.1), respectively. In addition, the serum hepcidin level was evaluated in allpatients to determine its correlation with the DAS28-ESR score.Results: There was no significant difference between the RA with ACD and RA without ACD groups interms of the median (interquartile range) hepcidin level (1207 [985.2] vs. 923.8 [677.3] ng/mL; P=0.57).Likewise, no significant difference was observed between the active RA and inactive to moderatelyactive RA groups in this regard (1131.8 [991.3] vs. 1090.9 [631.4] ng/mL; P=0.53).Conclusion: Hepcidin has no association with disease activity in RA. Therefore, it is not necessary tomeasure hepcidin to determine the RA activity.

🔖

Bu Makaleye Atıf Yap

KHODASHAHI, M., REZAIEYAZDI, Z., SAHEBARI, M., HASHEMY, S. I., KHORASANI, S., SHAHGORDI, S., ALIZADEH, M. K., GHAENI, A. (2022). Serum hepcidin level and rheumatoid arthritis disease activity. European Journal of Rheumatology, Cilt: 6 - Sayı: 2, 76–80. https://ajindex.com/articles/511615

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Melchiorre D, Iagnocco AM, Acharya S, Pepe G, Borderi M. Rheumatoid arthritis. Autoimmune Dis 2013
  2. 958437. [CrossRef] 2. Nishimoto N, Hashimoto J, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, et al. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis 2007
  3. [CrossRef] 3. Abdel-Khalek MA, El-Barbary AM, Essa SA, Ghobashi AS. Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis. J Rheumatol 2011
  4. [CrossRef] 4. Geerts I, Vermeersch P, Joosten E. Evaluation of the first commercial hepcidin ELISA for the differential diagnosis of anemia of chronic disease and iron deficiency anemia in hospitalized geriatric patients. ISRN Hematol 2012
  5. 567491. [CrossRef] 5. van Santen S, van Dongen-Lases EC, de Vegt F, Laarakkers CM, van Riel PL, van Ede AE, et al. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum 2011
  6. [CrossRef] 6. Demirag MD, Haznedaroglu S, Sancak B, Konca C, Gulbahar O, Ozturk MA, et al. Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis. Intern Med 2009
  7. [CrossRef] 7. Sellam J, Kotti S, Fellahi S, Bastard JP, Meyer M, Liote F, et al. Serum hepcidin level is not an independent surrogate biomarker of disease activity or of radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort. Ann Rheum Dis 2013
  8. [CrossRef] 8. Means RT, Jr. Hepcidin and anaemia. Blood Rev 2004
  9. [CrossRef] 9. Masson C. Rheumatoid anemia. Joint Bone Spine 2011
  10. [CrossRef] 10. Talukdar M, Barui G, Adhikari A, Karmakar R, Ghosh UC, Das TK. A Study on Association between Common Haematological Parameters and Disease Activity in Rheumatoid Arthritis. J Clin Diagn Res 2017
  11. Ec01-ec04. [CrossRef] 11. Kim HR, Kim KW, Yoon SY, Kim SH, Lee SH. Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis. J Korean Med Sci 2010
  12. [CrossRef] 12. Swellam M, Gabal KM, Youssef SS. Interleukin-1 receptor antagonist gene polymorphism and hepcidin in rheumatoid arthritis: Correlations with clinical and laboratory indices of disease activity. IUBMB Li